colorectal disease
Conditions
Interventions
C:15ml hempseed oil + 2L PEG+5% GS
A:3L PEG
B:15ml hempseed oil + 2L PEG
Sponsors
Lanzhou University First Hospital
Eligibility
Sex/Gender
All
Age
50 Years to 74 Years
Inclusion criteria
Inclusion criteria: 1. Subjects who received colonoscopy in each research center; 2. Male or female, aged 60-74 years (including 60 and 74 years old); 3. Necessary body fluid and blood electrolyte balance (potassium, The detection values ??of sodium, chloride,calcium, and magnesium do not exceed 10% of the normal range, including the critical value); 4. Voluntarily participate and sign informed consent
Exclusion criteria
Exclusion criteria: 1. Those who are allergic to any component of the investigational drug; 2. Those who cannot take drugs as required by the program; 3. Within 7 days before the start of the trial, have used study drugs or other bowel preparations, used drugs that affect gastrointestinal kinetics (such as prokinetic drugs, laxatives, etc.); 4. Severe heart, cerebrovascular disease, renal or hepatic insufficiency; 5. Women with positive pregnancy test or planning to become pregnant, lactating women; 6. Subjects who have participated in any other clinical trials within the past 3 months; 7. The investigator believes that the subject has any other circumstances that should not be selected
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Boston bowel preparation scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| the time of cecal intubation;adverse event;tolerance to recommended regime;Number of bowel movements until bowel preparation is successful;The patients willing to repeat the same bowel regime;detection rate of polyp and adenoma;The time of the first bowel movement after taking the medicine; | — |
Countries
China
Contacts
Public Contactmiaolong
????????
Outcome results
None listed